Literature DB >> 14646397

Differential effect of fetal, neonatal and treatment variables on neurodevelopment in infants with congenital hypothyroidism.

M Alvarez1, F Carvajal, A Renón, C Pérez, A Olivares, G Rodríguez, V Alvarez.   

Abstract

OBJECTIVES: To identify the influence of fetal, neonatal and treatment variables on neurodevelopment in children with congenital hypothyroidism.
METHODS: A multiple regression analysis was performed in the neurodevelopmental scores of 26 children with CH who were assessed at 3, 6, 12 and 18 months for postural control, fine eye-hand coordination and language. The independent variables were: duration of fetal hypothyroidism, initial biochemical severity, days at starting treatment, initial dose, and efficiency of treatment.
RESULTS: Postural control was predicted by duration of fetal hypothyroidism and language by the biochemical severity of the disease at birth. Fine eye-hand coordination was not predicted by any variable.
CONCLUSION: This pattern of influences suggests that fetal and neonatal hypothyroidism have different effects on brain maturation sites during the first 2 years of life and that some subtle neurocognitive deficits are probably unavoidable. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14646397     DOI: 10.1159/000075192

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  2 in total

1.  What has national screening program changed in cases with congenital hypothyroidism?

Authors:  Şebnem Özgelen; Veysel Nijat Baş; Semra Çetinkaya; Zehra Aycan
Journal:  Iran J Pediatr       Date:  2014-06       Impact factor: 0.364

Review 2.  Neuropsychological Alterations in Patients with Congenital Hypothyroidism Treated with Levothyroxine: Linked Factors and Thyroid Hormone Hyposensitivity.

Authors:  Karla Cristina Razón-Hernández; Norma Osnaya-Brizuela; Armando Valenzuela-Peraza; Esperanza Ontiveros-Mendoza; Luis Miguel Rodríguez-Serrano; Jorge Pacheco-Rosado; Gerardo Barragán-Mejía; Karla Sánchez-Huerta
Journal:  J Clin Med       Date:  2022-06-15       Impact factor: 4.964

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.